Disclosures for "Persistence to OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy Among Patients With Migraine: A Retrospective Cohort Study")
-
Dr. Talon has nothing to disclose.
-
Christine Sullivan has received personal compensation for serving as an employee of Lundbeck.
-
Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
-
Seema Soni-Brahmbhatt has nothing to disclose.
-
Mr. Anderson has nothing to disclose.
-
Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received research support from Emmes Corporation.
-
Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.